Logo of joncLink to Publisher's site
PMC full text:
Published online 2022 Sep 5. doi: 10.1155/2022/8227806
Copyright/LicenseRequest permission to reuse

Figure 8

An external file that holds a picture, illustration, etc. Object name is JO2022-8227806.008.jpg

Role of the risk signature in immunotherapeutic responses. (a) ESTIMATE algorithm was used to investigate the correlation between the two groups in immune scores and stromal scores. (b)–(e) The correlation between immunophenoscore and different risk groups. Low-risk subgroup was positively correlated with a lower IC50 of Docetaxel (f), Bleomycin (g), and Trametinb (j), while a higher IC50 of 5-Fluorouracil (h) and Mitomycin C (i). **p < 0.01, ***p < 0.001, ns p > 0.05.

Images in this article

  • Figure 1
  • Figure 2
  • Figure 3
  • Figure 4
  • Figure 5
  • Figure 6
  • Figure 7
  • Figure 8
  • Figure 9
Click on the image to see a larger version.